Literature DB >> 11865338

Differences between biopsy- or specimen-related Laurén and World Health Organization classification in gastric cancer.

Uta Flucke1, Stefan P Mönig, Stephan E Baldus, Thomas K Zirbes, Elfriede Bollschweiler, Jürgen Thiele, Hans P Dienes, Arnulf H Hölscher.   

Abstract

The extent of stomach resection in gastric cancer depends on tumor size, tumor location, depth of invasion, and the histological allocation to intestinal or diffuse type according to Laurén. As the latter is based on preoperative findings we performed a retrospective histomorphological study to quantify the differences between biopsy-related and surgical specimen-related Laurén classification. Additionally the World Health Organization (WHO) classification of preoperative endoscopic biopsies and surgical specimens were compared. Preoperative biopsies and resected tumor specimens from 100 patients with primary gastric carcinoma were retrospectively classified according toLaurén and WHO. The reclassification was independently performed by three pathologists who were not aware of the previous diagnoses. In 74% the Laurén classification of pre- and postoperative specimens was identical, whereas 26% of the cases showed a disagreement. Out of 48 tumors with preoperative diagnosis of an intestinal type, 10 tumors (20.8%) exhibited a diffuse growth pattern in the gastrectomy specimens; and 16% of the cases showed a disagreement of the pre- and postoperative histopathological type according to the WHO classification. Preoperative biopsy-related and surgical specimen-related Laurén classification differ in about one-quarter of the cases. Mostly, the preoperative diagnosis of an intestinal tumor type must be corrected into a diffuse or mixed type according to Laurén. Since this may have consequences for the surgical strategy, the extent of surgical resection, rebiopsies, and reconfirmation of an intestinal type should be performed at least in those cases with any doubts of this classification.

Entities:  

Mesh:

Year:  2001        PMID: 11865338     DOI: 10.1007/s00268-001-0195-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Is pretreatment endoscopic biopsy a good predictor of signet ring cell histology in gastric carcinoma?

Authors:  Guillaume Piessen; David Amielh; Mathieu Messager; Edouard Vinatier; Emmanuelle Leteurtre; Jean Pierre Triboulet; Christophe Mariette
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

2.  Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation.

Authors:  Olga Speck; Weihua Tang; Douglas R Morgan; Pei Fen Kuan; Michael O Meyers; Ricardo L Dominguez; Enrique Martinez; Margaret L Gulley
Journal:  Appl Immunohistochem Mol Morphol       Date:  2015-10

3.  Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance.

Authors:  Cheng-Bo Han; Jia-Ming Ma; Yan Xin; Xiao-Yun Mao; Yu-Jie Zhao; Dong-Ying Wu; Su-Min Zhang; Yu-Kui Zhang
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

Review 4.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Authors:  Felix Berlth; Elfriede Bollschweiler; Uta Drebber; Arnulf H Hoelscher; Stefan Moenig
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

5.  Overexpressed targeting protein for Xklp2 (TPX2) serves as a promising prognostic marker and therapeutic target for gastric cancer.

Authors:  Bo Liang; Wenjuan Zheng; Lu Fang; Linquan Wu; Fan Zhou; Xiangbao Yin; Xin Yu; Zhenhong Zou
Journal:  Cancer Biol Ther       Date:  2016-06-17       Impact factor: 4.742

6.  Identification of Stemness Characteristics Associated With the Immune Microenvironment and Prognosis in Gastric Cancer.

Authors:  Deli Mao; Zhijun Zhou; Shenglei Song; Dongsheng Li; Yulong He; Zhewei Wei; Changhua Zhang
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

7.  Prediagnosis lifestyle exposures and survival of gastric cancer patients: a cohort study from Portugal.

Authors:  I Ferronha; C Castro; H Carreira; M J Bento; I Carvalho; B Peleteiro; N Lunet
Journal:  Br J Cancer       Date:  2012-06-14       Impact factor: 7.640

8.  Feasibility of differentiating T3 from T4a gastric cancer in different Lauren classification by determining serosa invasion: Diagnostic performance of high enhanced serosa sign.

Authors:  Rui-Jia Sun; Lei Tang; Ying Chen; Xiao-Ting Li; Yu Sun; Zi-Yu Li; Ying-Shi Sun
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

Review 9.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

10.  Growth hormone receptor expression in human primary gastric adenocarcinoma.

Authors:  Xiaodong Yang; Ping Huang; Feng Wang; Zekuan Xu; Xiaonin Wang
Journal:  J Biomed Res       Date:  2012-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.